NUTX (Nutex Health) Asset Turnover: 0.22 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NUTX Nutex Health Inc NUTX
75 GF Score
Price $191.34
GF Value $82.60
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nutex Health Asset Turnover?

Nutex Health NUTX -1.32% 75 Asset Turnover is 0.22 as of Jun. 2026. GuruFocus rates NUTX with a GF Score™ of 75/100 and a GF Value™ of $82.60 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Nutex Health's Revenue for the three months ended in Jun. 2026 was $210.8 Mil. Nutex Health's Total Assets for the quarter that ended in Jun. 2026 was $961.0 Mil. Therefore, Nutex Health's Asset Turnover for the quarter that ended in Jun. 2026 was 0.22.

Asset Turnover is linked to ROE % through Du Pont Formula. Nutex Health's annualized ROE % for the quarter that ended in Jun. 2026 was 71.12%. It is also linked to ROA % through Du Pont Formula. Nutex Health's annualized ROA % for the quarter that ended in Jun. 2026 was 27.41%.


Nutex Health  (NAS:NUTX) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Nutex Health's annulized ROE % for the quarter that ended in Jun. 2026 is

ROE %**(Q: Jun. 2026 )
=Net Income/Total Stockholders Equity
=263.368/370.3045
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(263.368 / 843.008)*(843.008 / 960.9735)*(960.9735/ 370.3045)
=Net Margin %*Asset Turnover*Equity Multiplier
=31.24 %*0.8772*2.5951
=ROA %*Equity Multiplier
=27.41 %*2.5951
=71.12 %

Note: The Net Income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Nutex Health's annulized ROA % for the quarter that ended in Jun. 2026 is

ROA %(Q: Jun. 2026 )
=Net Income/Total Assets
=263.368/960.9735
=(Net Income / Revenue)*(Revenue / Total Assets)
=(263.368 / 843.008)*(843.008 / 960.9735)
=Net Margin %*Asset Turnover
=31.24 %*0.8772
=27.41 %

Note: The Net Income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Nutex Health Asset Turnover Related Terms


Nutex Health Asset Turnover Historical Data

* Premium members only.

The historical data trend for Nutex Health's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutex Health Asset Turnover Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
Get a 7-Day Free Trial 0.94 0.53 0.60 0.91 1.11

Nutex Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.30 0.16 0.23 0.22

NUTX vs USPH, AMN, GMRS: Asset Turnover Comparison

For the Medical Care Facilities subindustry, Nutex Health's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutex Health Asset Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Nutex Health's Asset Turnover falls into.


NUTX
75GF Score
Nutex Health Inc NUTX
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutex Health Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Nutex Health's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=875.257/( (655.32+918.525)/ 2 )
=875.257/786.9225
=1.11

Nutex Health's Asset Turnover for the quarter that ended in Jun. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2026 )/( (Total Assets (Q: Mar. 2026 )+Total Assets (Q: Jun. 2026 ))/ count )
=210.752/( (957.318+964.629)/ 2 )
=210.752/960.9735
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.22 mean?
Nutex Health (NUTX) has a Asset Turnover of 0.22 as of Jun. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Nutex Health and its competitors.
Is Nutex Health's Asset Turnover too high?
Nutex Health's current Asset Turnover is 0.22. Overall, Nutex Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's Asset Turnover compare to USPH and AMN?
Nutex Health's Asset Turnover of 0.22 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Healthcare Providers & Services company?
A good Asset Turnover depends on the Healthcare Providers & Services industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Nutex Health and its competitors. Nutex Health's current Asset Turnover is 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (NUTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $82.60, compared to a current price of $191.34 — trading 131.6% above its estimated fair value. The current Asset Turnover is 0.22. Nutex Health's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Nutex Health (NUTX), the current Asset Turnover is 0.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutex Health (NUTX) Overvalued in 2026?

Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued. The current stock price of $191.34 is trading 131.6% above its estimated GF Value™ of $82.60. GuruFocus considers Nutex Health to be Significantly Overvalued.

Key valuation signals for NUTX:

  • Asset Turnover: 0.22
  • GF Value™: $82.60 vs. price of $191.34 (131.6% above fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the NUTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nutex Health Business Description

Other Exchanges 5LF:Germany
Address 1776 Yorktown Street, Suite 700, Houston, TX, USA, 77056
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
75GF Score

Get the complete analysis for NUTX

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$191.34
Price
$82.60
GF Value